Migraine and dietary factors: a narrative review of current evidence and clinical implications
DOI:
https://doi.org/10.48208/HeadacheMed.2026.11Palavras-chave:
Migraine, Dietary triggers, Diet, Nutritional therapyResumo
Background
Dietary factors have been extensively examined as potential triggers or modulators of migraine episodes. Nevertheless, the current body of evidence concerning the influence of diet on the pathophysiology and management of migraines remains varied and occasionally contradictory.
Objective
To critically evaluate the existing evidence concerning the association between dietary factors and migraine, with a focus on potential triggers, dietary patterns, and the gut–brain axis.
Methods
This study employs a narrative review of the literature, concentrating on research that examines dietary triggers, nutritional interventions, and the pathophysiological mechanisms associated with migraine.
Results
Certain dietary components, including caffeine, chocolate, alcohol, and foods containing histamine, have been linked to the onset of migraine attacks in susceptible individuals, although findings remain inconsistent. Various dietary interventions—such as low-fat diets, ketogenic diets, low-glycemic diets, and diets enriched with omega-3 fatty acids—have demonstrated potential benefits in reducing the frequency and severity of migraines.
Conclusions
Dietary factors may affect migraine in a subset of patients through metabolic, inflammatory, and neurovascular pathways. Further well-designed prospective studies are necessary before definitive clinical recommendations can be formulated.
Downloads
Referências
1. Gibb C, Davies P, Glover V, Steiner T, Rose FC, Sandler M. Chocolate is a Migraine-Provoking Agent. Cephalalgia 1991;11:93–5. Doi:10.1046/j.1468-2982.1991.1102093.x. DOI: https://doi.org/10.1046/j.1468-2982.1991.1102093.x
2. Marcus D, Scharff L, Turk D, Gourley L. A Double-Blind Provocative Study Chocolate as A Trigger of Headache. Cephalalgia 1997;17:855–62. Doi:10.1046/j.1468-2982.1997.1708855.x. DOI: https://doi.org/10.1046/j.1468-2982.1997.1708855.x
3. Park J-W, Chu MK, Kim J-M, Park S-G, Cho S-J. Analysis of Trigger Factors in Episodic Migraineurs Using a Smartphone Headache Diary Applications. PLoS One 2016;11:1–13. Doi:10.1371/journal.pone.0149577. DOI: https://doi.org/10.1371/journal.pone.0149577
4. Charles A. The Evolution of a Migraine Attack – A Review of Recent Evidence. Headache: The Journal of Head and Face Pain 2013;53:413–9. Doi:10.1111/head.12026. DOI: https://doi.org/10.1111/head.12026
5. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007;47:1418–26. Doi:10.1111/j.1526-4610.2007.00776.x. DOI: https://doi.org/10.1111/j.1526-4610.2007.00776.x
6. Guillén-Casla V, Rosales-Conrado N, León-González ME, Pérez-Arribas L V, Polo-Díez LM. Determination of serotonin and its precursors in chocolate samples by capillary liquid chromatography with mass spectrometry detection. J Chromatogr A 2012;1232:158–65. Doi:10.1016/j.chroma.2011.11.037. DOI: https://doi.org/10.1016/j.chroma.2011.11.037
7. Razeghi Jahromi S, Togha M, Ghorbani Z, Hekmatdoost A, Khorsha F, Rafiee P, et al. The association between dietary tryptophan intake and migraine. Neurol Sci 2019;40:2349–55. Doi:10.1007/s10072-019-03984-3. DOI: https://doi.org/10.1007/s10072-019-03984-3
8. Magrone T, Russo MA, Jirillo E. Cocoa and Dark Chocolate Polyphenols: From Biology to Clinical Applications. Front Immunol 2017;8:1–13. Doi:10.3389/fimmu.2017.00677. DOI: https://doi.org/10.3389/fimmu.2017.00677
9. Ludovici V, Barthelmes J, Nägele MP, Enseleit F, Ferri C, Flammer AJ, et al. Cocoa, Blood Pressure, and Vascular Function. Front Nutr 2017;4:1–12. Doi:10.3389/fnut.2017.00036. DOI: https://doi.org/10.3389/fnut.2017.00036
10. Cady RJ, Durham PL. Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neurons. Brain Res 2010;1323:18–32. Doi:10.1016/j.brainres.2010.01.081. DOI: https://doi.org/10.1016/j.brainres.2010.01.081
11. Nowaczewska M, Wiciński M, Kaźmierczak W, Kaźmierczak H. To Eat or Not to Eat: A Review of the Relationship between Chocolate and Migraines. Nutrients 2020;12:1–16. Doi:10.3390/nu12030608. DOI: https://doi.org/10.3390/nu12030608
12. Espinosa Jovel CA, Sobrino Mejía FE. Caffeine and headache: specific remarks. Neurologia 2017;32:394–8. Doi:10.1016/j.nrl.2014.12.016. DOI: https://doi.org/10.1016/j.nrleng.2014.12.022
13. Jones HE, Herning RI, Cadet JL, Griffiths RR. Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology (Berl) 2000;147:371–7. Doi:10.1007/s002130050005. DOI: https://doi.org/10.1007/s002130050005
14. Dunwiddie T V, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001;24:31–55. Doi:10.1146/annurev.neuro.24.1.31. DOI: https://doi.org/10.1146/annurev.neuro.24.1.31
15. Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ. The influence of a low-fat diet on incidence and severity of migraine headaches. J Womens Health Gend Based Med 1999;8:623–30. Doi:10.1089/jwh.1.1999.8.623. DOI: https://doi.org/10.1089/jwh.1.1999.8.623
16. Ferrara LA, Pacioni D, Di Fronzo V, Russo BF, Speranza E, Carlino V, et al. Low-lipid diet reduces frequency and severity of acute migraine attacks. Nutr Metab Cardiovasc Dis 2015;25:370–5. Doi:10.1016/j.numecd.2014.12.006. DOI: https://doi.org/10.1016/j.numecd.2014.12.006
17. Soveyd N, Abdolahi M, Bitarafan S, Tafakhori A, Sarraf P, Togha M, et al. Molecular mechanisms of omega-3 fatty acids in the migraine headache. Iran J Neurol 2017;16:210–7. DOI: https://doi.org/10.2174/1871527317666171213154749
18. Tajmirriahi M, Sohelipour M, Basiri K, Shaygannejad V, Ghorbani A, Saadatnia M. The effects of sodium valproate with fish oil supplementation or alone in migraine prevention: A randomized single-blind clinical trial. Iran J Neurol 2012;11:21–4.
19. Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health 2002;31:154–61. Doi:10.1016/s1054-139x(02)00349-x. DOI: https://doi.org/10.1016/S1054-139X(02)00349-X
20. Sanders AE, Shaikh SR, Slade GD. Long-chain omega-3 fatty acids and headache in the U.S. population. Prostaglandins Leukot Essent Fatty Acids 2018;135:47–53. Doi:10.1016/j.plefa.2018.06.008. DOI: https://doi.org/10.1016/j.plefa.2018.06.008
21. Ramsden CE, Faurot KR, Zamora D, Suchindran CM, MacIntosh BA, Gaylord S, et al. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain 2013;154:2441–51. Doi:10.1016/j.pain.2013.07.028. DOI: https://doi.org/10.1016/j.pain.2013.07.028
22. Sadeghifar F, Penry VB. Mechanisms and Uses of Dietary Therapy as a Treatment for Epilepsy: A Review. Glob Adv Health Med 2019;8:1–4. Doi:10.1177/2164956119874784. DOI: https://doi.org/10.1177/2164956119874784
23. Barbanti P, Fofi L, Aurilia C, Egeo G, Caprio M. Ketogenic diet in migraine: rationale, findings and perspectives. Neurol Sci 2017;38:111–5. Doi:10.1007/s10072-017-2889-6. DOI: https://doi.org/10.1007/s10072-017-2889-6
24. Oliveira MAR de, Ataíde T da R, Oliveira SL de, Lucena AL de M, Lira CEPR de, Soares AA, et al. Effects of short-term and long-term treatment with medium- and long-chain triglycerides ketogenic diet on cortical spreading depression in young rats. Neurosci Lett 2008;434:66–70. Doi:10.1016/j.neulet.2008.01.032. DOI: https://doi.org/10.1016/j.neulet.2008.01.032
25. Jeong EA, Jeon BT, Shin HJ, Kim N, Lee DH, Kim HJ, et al. Ketogenic diet-induced peroxisome proliferator-activated receptor-γ activation decreases neuroinflammation in the mouse hippocampus after kainic acid-induced seizures. Exp Neurol 2011;232:195–202. Doi:10.1016/j.expneurol.2011.09.001. DOI: https://doi.org/10.1016/j.expneurol.2011.09.001
26. Schnabel TG. An Experience with a Ketogenic Dietary in Migraine. Ann Intern Med 1928;2:341–7. Doi:10.7326/0003-4819-2-4-341. DOI: https://doi.org/10.7326/0003-4819-2-4-341
27. Barborka CJ. Migraine. J Am Med Assoc 1930;95:1825–8. Doi:10.1001/jama.1930.02720240035010. DOI: https://doi.org/10.1001/jama.1930.02720240035010
28. Di Lorenzo C, Coppola G, Sirianni G, Pierelli F. Short term improvement of migraine headaches during ketogenic diet: a prospective observational study in a dietician clinical setting. J Headache Pain 2013;14. Doi:10.1186/1129-2377-14-S1-P219. DOI: https://doi.org/10.1186/1129-2377-14-S1-P219
29. Di Lorenzo C, Coppola G, Sirianni G, Di Lorenzo G, Bracaglia M, Di Lenola D, et al. Migraine improvement during short lasting ketogenesis: a proof-of-concept study. Eur J Neurol 2015;22:170–7. Doi:10.1111/ene.12550. DOI: https://doi.org/10.1111/ene.12550
30. Di Lorenzo C, Coppola G, Bracaglia M, Di Lenola D, Evangelista M, Sirianni G, et al. Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet in migraine: a multimodal evoked potentials study. J Headache Pain 2016;17:1–10. Doi:10.1186/s10194-016-0650-9. DOI: https://doi.org/10.1186/s10194-016-0650-9
31. Namazi N, Heshmati J, Tarighat-Esfanjani A. Supplementation with Riboflavin (Vitamin B2) for Migraine Prophylaxis in Adults and Children: A Review. Int J Vitam Nutr Res 2015;85:79–87. Doi:10.1024/0300-9831/a000225. DOI: https://doi.org/10.1024/0300-9831/a000225
32. Domitrz I, Cegielska J. Magnesium as an Important Factor in the Pathogenesis and Treatment of Migraine-From Theory to Practice. Nutrients 2022;14:1–12. Doi:10.3390/nu14051089. DOI: https://doi.org/10.3390/nu14051089
33. Arzani M, Jahromi SR, Ghorbani Z, Vahabizad F, Martelletti P, Ghaemi A, et al. Gut-brain Axis and migraine headache: a comprehensive review. J Headache Pain 2020;21:1–12. Doi:10.1186/s10194-020-1078-9. DOI: https://doi.org/10.1186/s10194-020-1078-9
34. Vuralli D, Ceren Akgor M, Dagidir HG, Onat P, Yalinay M, Sezerman U, et al. Microbiota alterations are related to migraine food triggers and inflammatory markers in chronic migraine patients with medication overuse headache. J Headache Pain 2024;25:1–16. Doi:10.1186/s10194-024-01891-3. DOI: https://doi.org/10.1186/s10194-024-01891-3
35. Razeghi Jahromi S, Ghorbani Z, Martelletti P, Lampl C, Togha M, School of Advanced Studies of the European Headache Federation (EHF-SAS). Association of diet and headache. J Headache Pain 2019;20:1–11. Doi:10.1186/s10194-019-1057-1. DOI: https://doi.org/10.1186/s10194-019-1057-1
36. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211. Doi:10.1177/0333102417738202. DOI: https://doi.org/10.1177/0333102417738202
37. Reese I, Ballmer-Weber B, Beyer K, Fuchs T, Kleine-Tebbe J, Klimek L, et al. German guideline for the management of adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Association of Allergologists (AeDA), and the Swiss Society for Allergology and Immunology (SGAI). Allergo J Int 2017;26:72–9. Doi:10.1007/s40629-017-0011-5. DOI: https://doi.org/10.1007/s40629-017-0011-5
38. Schwelberger HG. Histamine intolerance: a metabolic disease? Inflamm Res 2010;59 Suppl 2:219–21. Doi:10.1007/s00011-009-0134-3. DOI: https://doi.org/10.1007/s00011-009-0134-3
39. Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr 2007;85:1185–96. Doi:10.1093/ajcn/85.5.1185. DOI: https://doi.org/10.1093/ajcn/85.5.1185
40. Panconesi A. Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain 2008;9:19–27. Doi:10.1007/s10194-008-0006-1. DOI: https://doi.org/10.1007/s10194-008-0006-1
41. Parsons ME, Ganellin CR. Histamine and its receptors. Br J Pharmacol 2006;147:127–35. Doi:10.1038/sj.bjp.0706440. DOI: https://doi.org/10.1038/sj.bjp.0706440
42. Leurs R, Chazot PL, Shenton FC, Lim HD, de Esch IJP. Molecular and biochemical pharmacology of the histamine H4 receptor. Br J Pharmacol 2009;157:14–23. Doi:10.1111/j.1476-5381.2009.00250.x. DOI: https://doi.org/10.1111/j.1476-5381.2009.00250.x
43. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48–56. Doi:10.1002/ana.410330109. DOI: https://doi.org/10.1002/ana.410330109
44. Izquierdo-Casas J, Comas-Basté O, Latorre-Moratalla ML, Lorente-Gascón M, Duelo A, Vidal-Carou MC, et al. Low serum diamine oxidase (DAO) activity levels in patients with migraine. J Physiol Biochem 2018;74:93–9. Doi:10.1007/s13105-017-0571-3. DOI: https://doi.org/10.1007/s13105-017-0571-3
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2026 Ernesto Bancalari, Ursula Rosa Huerta Robles, Karol Melissa Solórzano Palacios , Katherine Zulema Bendezú Sánchez, Jorge Aleberto Giglio, Cecilia Odette Cardenas Bedecarratz, Fiorella Francisca Celsi Young, Wilder Gonzales Chumbipuma (Author)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
